Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "European Radiology"
DOI: 10.1007/s00330-022-08607-8
Abstract: To reveal a radiogenomic correlation between the presence of the T2-fluid-attenuated inversion recovery resection (T2-FLAIR) mismatch sign on MR images and isocitrate dehydrogenase (IDH) mutation status in adult patients with lower-grade gliomas (LGGs). A web-based…
read more here.
Keywords:
mismatch sign;
sign;
flair mismatch;
idh mutation ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2020 at "Neuro-oncology"
DOI: 10.1093/neuonc/noaa041
Abstract: The T2-FLAIR mismatch sign is an easily detectable imaging sign on routine clinical MRI studies that suggests diagnosis of IDH-mutant 1p/19q non-codeleted gliomas. Multiple independent studies show that the T2-FLAIR mismatch sign has near-perfect specificity,…
read more here.
Keywords:
flair mismatch;
idh mutant;
sign;
imaging sign ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "European Journal of Neurology"
DOI: 10.1111/ene.13580
Abstract: The DAWN trial recently showed compelling evidence in treating late window and wake‐up stroke patients with thrombectomy using a clinical‐imaging mismatch. The aim was to evaluate the results of thrombectomy for unknown‐onset strokes (UOS) treated…
read more here.
Keywords:
flair mismatch;
dwi flair;
onset strokes;
unknown onset ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of veterinary internal medicine"
DOI: 10.1111/jvim.16749
Abstract: BACKGROUND In humans, the T2-weighted (T2W)-fluid-attenuated inversion recovery (FLAIR) mismatch sign (T2FMM) is a specific imaging biomarker for the isocitrate dehydrogenase 1 (IDH1)-mutated, 1p/19q non-codeleted low-grade astrocytomas (LGA). The T2FMM is characterized by a homogeneous…
read more here.
Keywords:
flair mismatch;
biomarker;
t2fmm;
mismatch sign ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-17-0560
Abstract: Purpose: Lower-grade gliomas (WHO grade II/III) have been classified into clinically relevant molecular subtypes based on IDH and 1p/19q mutation status. The purpose was to investigate whether T2/FLAIR MRI features could distinguish between lower-grade glioma…
read more here.
Keywords:
flair mismatch;
mismatch sign;
lower grade;
flair ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Neurology"
DOI: 10.1212/wnl.0000000000010324
Abstract: Objective To assess the predictive value of T2 appearance as a defining criterion of T2–fluid-attenuated inversion recovery (FLAIR) mismatch sign (T2FM), further characterize tumors that display the marker, and describe its radiographic evolution. Methods Records…
read more here.
Keywords:
flair rim;
astrocytomas;
flair;
flair mismatch ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s351943
Abstract: Purpose To compare the MRI characteristics of patients with wake-up ischemic stroke (WUS) and with ischemic stroke with known onset time (clear-onset-time stroke, COS) to clarify the role of diffusion-weighted imaging–fluid-attenuated inversion recovery (DWI-FLAIR) mismatch…
read more here.
Keywords:
flair mismatch;
flair;
dwi flair;
onset time ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2023 at "Brain Sciences"
DOI: 10.3390/brainsci13020287
Abstract: No definitive blood markers of DWI-FLAIR mismatch, a pivotal indicator of salvageable ischemic penumbra brain tissue, are known. We previously reported that CDC42 and RHOA are associated with the ischemic penumbra. Here, we investigated whether…
read more here.
Keywords:
flair mismatch;
dwi flair;
flair;
cdc42 ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15092503
Abstract: Simple Summary The preoperative risk estimation of non-enhancing suspected “low-grade” glioma (NEG) is key in determining the optimal timing of diagnosis and treatment to delay malignant progression and avoid undertreatment. The updated 2021 WHO classification…
read more here.
Keywords:
flair mismatch;
non enhancing;
mismatch sign;
risk estimation ... See more keywords